TrialCancer chemotherapy and pharmacology2021
Time-dependent population PK models of single-agent atezolizumab in patients with cancer.
Mathilde Marchand et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this paperpooled ittrialcites it